Functionalization of NaGdF4 nanoparticles with a dibromomaleimide-terminated polymer for MR/optical imaging of thrombosis

2020 ◽  
Vol 11 (5) ◽  
pp. 1010-1017 ◽  
Author(s):  
Yuhuan Li ◽  
Fangyun Xin ◽  
Jinming Hu ◽  
Shweta Jagdale ◽  
Thomas P. Davis ◽  
...  

A thrombosis-targeted molecular imaging probe with magnetic resonance (MR) and optical dual-modality capacity using dibromomaleimide (DBM)-bearing polymer-grafted NaGdF4 nanoparticles.

RSC Advances ◽  
2016 ◽  
Vol 6 (29) ◽  
pp. 24104-24110 ◽  
Author(s):  
Wei Lu ◽  
Ning Wang ◽  
YanYan Chu ◽  
Linzhu Zhou ◽  
Maolan Li ◽  
...  

CLIC1 antibody-conjugated nano-scale contrast agents exhibit a fast and sensitive detection of gallbladder tumors and may be used in the future as powerful targeted molecular imaging probes for gallbladder cancer diagnosis.


Biomaterials ◽  
2020 ◽  
Vol 256 ◽  
pp. 120220
Author(s):  
Huaixin Zhao ◽  
Huiting Zhao ◽  
Yi Jiao ◽  
Yi Zhu ◽  
Chunxia Liu ◽  
...  

2015 ◽  
Vol 51 (86) ◽  
pp. 15637-15640 ◽  
Author(s):  
A. Faust ◽  
T. Völler ◽  
F. Busch ◽  
M. Schäfers ◽  
J. Roth ◽  
...  

We describe the development and first evaluation of a novel S100A9 specific molecular imaging probe (Cy5.5-CES271) for optical imaging of local inflammatory activity in vivo.


2011 ◽  
Vol 10 (6) ◽  
pp. 7290.2011.00003 ◽  
Author(s):  
Fred Reynolds ◽  
Kimberly A. Kelly

Molecular imaging allows clinicians to visualize disease-specific molecules, thereby providing relevant information in the diagnosis and treatment of patients. With advances in genomics and proteomics and underlying mechanisms of disease pathology, the number of targets identified has significantly outpaced the number of developed molecular imaging probes. There has been a concerted effort to bridge this gap with multidisciplinary efforts in chemistry, proteomics, physics, material science, and biology—all essential to progress in molecular imaging probe development. In this review, we discuss target selection, screening techniques, and probe optimization with the aim of developing clinically relevant molecularly targeted imaging agents.


APOPTOSIS ◽  
2012 ◽  
Vol 18 (2) ◽  
pp. 238-247 ◽  
Author(s):  
Ming-Wei Wang ◽  
Fang Wang ◽  
Yu-Jia Zheng ◽  
Ying-Jian Zhang ◽  
Yong-Ping Zhang ◽  
...  

2017 ◽  
Vol 851 ◽  
pp. 012014 ◽  
Author(s):  
P Moradi Khaniabadi ◽  
A. M. S.A Majid ◽  
M Asif ◽  
B Moradi Khaniabadi ◽  
D Shahbazi-Gahrouei ◽  
...  

2020 ◽  
Vol 11 (18) ◽  
pp. 4773-4778
Author(s):  
Yanyan Zhao ◽  
Ole Tietz ◽  
Wei-Li Kuan ◽  
Abdul K. Haji-Dheere ◽  
Stephen Thompson ◽  
...  

pTP-TFE imaging probe can distinguish soluble tau aggregated proteins from other aggregated proteins enabling earlier detection of neurodegenerative diseases.


Sign in / Sign up

Export Citation Format

Share Document